Correlating anterior insula gray matter volume changes in young people with clinical and neurocognitive outcomes: an MRI study

Abstract

Background

The anterior insula cortex is considered to be both the structural and functional link between experience, affect, and behaviour. Magnetic resonance imaging (MRI) studies have shown changes in anterior insula gray matter volume (GMV) in psychosis, bipolar, depression and anxiety disorders in older patients, but few studies have investigated insula GMV changes in young people. This study examined the relationship between anterior insula GMV, clinical symptom severity and neuropsychological performance in a heterogeneous cohort of young people presenting for mental health care.

Methods

Participants with a primary diagnosis of depression (n = 43), bipolar disorder (n = 38), psychosis (n = 32), anxiety disorder (n = 12) or healthy controls (n = 39) underwent structural MRI scanning, and volumetric segmentation of the bilateral anterior insula cortex was performed using the FreeSurfer application. Statistical analysis examined the linear and quadratic correlations between anterior insula GMV and participants’ performance in a battery of clinical and neuropsychological assessments.

Results

Compared to healthy participants, patients had significantly reduced GMV in the left anterior insula (t = 2.05, p = .042) which correlated with reduced performance on a neuropsychological task of attentional set-shifting (ρ = .32, p = .016). Changes in right anterior insula GMV was correlated with increased symptom severity (r = .29, p = .006) and more positive symptoms (r = .32, p = .002).

Conclusions

By using the novel approach of examining a heterogeneous cohort of young depression, anxiety, bipolar and psychosis patients together, this study has demonstrated that insula GMV changes are associated with neurocognitive deficits and clinical symptoms in such young patients.

Background

Located between the frontal, temporal and parietal lobes, the insular cortex processes a vast array of information including visceral sensory, visceral motor, vestibular, pain, temperature, language, visual, auditory, and tactile information [1,2]. A meta-analysis of 162 functional neuroimaging studies [3] highlights that the anterior insula is consistently activated during the expression of emotion including anger [4], sadness [4], fear [5], disgust [6], happiness or joy [7-9], trust [10], and surprise [11], as well as social emotions [reviewed in [12]]. Furthermore, the anterior insula has been implicated in visual-tactile [13] and auditory-visual [14] integration, as well as olfactory and gustatory function [15-17], suggesting that the insular cortex integrates these special visceral senses with behavioural and emotional events [18,19]. These processes arise through elaborate and extensive structural connections between the insula and various cortical, basal nuclei, limbic and thalamic areas [reviewed in [20]]. Thus, the insular cortex is considered to be the structural and functional link between experience, affect, and behaviour [21].

Functional network analysis suggests that the insular cortex processes information through high-level cognitive control and attentional processes, mediating “salience switching” between other large functional networks involved in externally-oriented attention and internally-oriented cognition [reviewed in [22]]. Functional magnetic resonance imaging (fMRI) studies have reported that the bilateral anterior insula, together with the anterior cingulate cortex, show increased activation during working memory, target switching and cognitive control tasks [23,24]. Furthermore, an fMRI study on attentional transitioning found that the bilateral anterior insula and anterior cingulate cortex operate as a cognitive-control network, and that the right anterior insula plays an essential role of switching between the central executive network and the default-network [25]. Cumulatively, the insular cortex, and in particular the anterior insula, appears to mediate the processing of experience, affect and behaviour [21] via high-level executive functioning and salience switching [22].

Changes in insula GMV have been implicated in the aetiology of many common psychiatric disorders in older patients. Meta-analysis of magnetic resonance imaging (MRI) studies has demonstrated significant insula GMV loss in bipolar disorders [26-29] and psychosis [26,30-34], and to a lesser extent in anxiety disorders [35-37]. The findings relating to unipolar depression appear to be less consistent, with some demonstrating no association [38-41], and others showing insula GMV loss in patients with depression [42,43]. However, as the interpretation of insula changes in older patients is confounded by long illness durations, associated lifestyle factors and up to 20 years of medication use, it is important to examine if changes in anterior insula GMV is evident in young patients at the early stages of disease progression. A voxel-based morphometry (VBM) meta-analysis [44] summarised that, in comparison to healthy controls, young subjects at enhanced clinical risk for psychosis exhibited reduced GMV in the left insular cortex. A meta-analysis of MRI abnormalities in young patients with bipolar disorder [45] reported that most studies found gray matter loss in the subgenual, prefrontal and temporal regions, though findings between studies were inconsistent. Lagopoulos et al. [46] conducted a cross-sectional VBM analysis of 47 young people with a heterogeneous mixture of depressive and psychosis symptoms, finding that compared to healthy controls, patients at early stages of illness had GMV reductions in the left insula, and this GMV loss was exacerbated in patients at later stages of disease progression. Examining changes within the insula of young people with emerging disorders would thus inform models of pathophysiology that link underlying neurobiological changes with key symptoms, helping to inform early detection and targeted intervention strategies [47-50].

In this study, we therefore aimed to determine whether: a) young people with an emerging anxious, affective or psychotic illness demonstrate evidence of anterior insular change, relative to their age-matched controls; and b) changes in the anterior insula relate to clinical symptoms and neuropsychological performance, specifically in the domain of executive functioning.

Methods

Participants

One hundred and thirty three outpatients aged 16 to 30 years were recruited from specialist youth mental health clinics in Sydney Australia [51,52]. Thirty-nine healthy controls were recruited from the community in the same region, and were screened for history of psychiatric disorders.

Exclusion criteria for both patients and controls were medical instability (as determined by a psychiatrist), history of neurological disease (e.g. tumour, head trauma, epilepsy), medical illness known to impact cognitive and brain function (e.g. cancer), intellectual and/or developmental disability, insufficient English for neuropsychological assessment and current substance dependence. All participants were asked to abstain from drug or alcohol use for 48 hours prior to testing and informed about a drug screen protocol. To verify recent abstinence, participants underwent an alcohol breath test and a saliva drug screen to determine presence of cannabinoids, meth/amphetamines, opiates, benzodiazepines and cocaine. The study was approved by the University of Sydney ethics committee. Participants gave written informed consent prior to participation in the study.

Patients were determined to have a primary diagnosis of depression (n = 43), bipolar disorder (n = 38), psychosis (n = 32) or anxiety disorder (n = 12) by a psychiatrist, according to DSM-IV-TR criteria [53]. At the time of assessment, 15% of patients were not taking any psychotropic medications; 51% were taking a second-generation antidepressants, 42% an atypical antipsychotic medication, 7% were taking a mood stabiliser and 2% were taking stimulants. Of those medicated, 48% were taking more than one of these psychotropic medications; for the majority of these patients (40% of those medicated) this polytherapy included an anti-psychotic.

Clinical assessment

All participants underwent clinical and neuropsychological assessment as previously described [54,55]. A psychiatrist conducted the clinical assessment (in a semi-structured interview format) to inform the diagnostic classification and to determine the nature and history of any mental health problems. Participants’ educational level was assessed as the cumulative completed number of years in school, university and/or advanced diploma course. The assessment included the Social and Occupational Functioning Assessment scale [SOFAS; [56]] to assess general social and occupational functioning, the Hamilton Depression Rating Scale [HDRS, 17-item; [57]] to quantify current (over the last 7 days) mood symptoms, and the Brief Psychiatric Rating Scale [BPRS; [58]] to quantify current general psychiatric symptom severity. The 24-point BPRS Total score is further subtyped by subscores assessing depression (somatic concern, anxiety, depression, suicidality, guilt, self-neglect), positive symptoms (hostility, grandiosity, suspiciousness, hallucinations, unusual thought content, bizarre behaviour, conceptual disorganization), negative symptoms (self-neglect, blunted affect, emotional withdrawal, motor retardation, uncooperativeness), mania (elated mood, conceptual disorganisation, tension, uncooperativeness, excitement, distractibility, motor hyperactivity) and disorientation (disorientation, mannerisms & posturing). As the BPRS disorientation subscore comprises of only two items, the measure was not considered statistically robust and was omitted from this study.

Self-report

All participants completed a self-report assessment that included: the Kessler-10 [K-10; [59]] which is a brief instrument designed to detect psychological distress [60]; the Depression Anxiety and Stress Scales [DASS; [61]], which measures the three related negative emotional states of depression, anxiety, and tension/stress; and, the Social Interaction Anxiety Scale [SIAS; [62]] which measures social interaction anxiety.

Neuropsychological assessment

As part of a broader battery [described previously, [54,55,63]], a trained research psychologist administered standardised tests to examine the following functions:

a) Premorbid IQ: This was estimated from the Wechsler Test of Adult Reading [64] where participants are scored on their ability to pronounce 50 English language words of increasing complexity.

b) Mental flexibility: The Trail-Making Test part B assessed “mental flexibility” [TMT-B; [65]], whereby participants were required to draw a line connecting consecutive targets alternating between numbers and letters. Raw timed scores were converted to age-adjusted z-scores according to normative date [66].

c) Verbal fluency: This was assessed via a subtest of the Controlled Oral Word Association Test [COWAT; [65]] which assessed the generation of words starting with the letters F, A and S, within a one-minute interval. Age- and educational-adjusted z-scores were derived from normative data [66].

d) Set-shifting: This was measured using the Intra-Dimensional/ Extra-Dimensional task (IED) from the Cambridge Automated Neuropsychological Testing Battery [CANTAB; [67]]. The total error score (adjusted) was used, measuring the subject’s efficiency to attend to specific attributes of compound stimuli (e.g. a line and a shape), then shift attention from one attribute (e.g. select the shape) to another (e.g. now select the line).

e) Sustained attention: This was measured via the Rapid Visual Information Processing task (RVP-A), of the CANTAB [67]. The A prime measure was used, reflecting the participant’s accuracy at detecting a target sequence of numbers (e.g. 4-5-3) within 2 minutes of pseudo-random numbers (e.g. 3-6-9-4-5-3-7- etc.).

f) Spatial working memory: This was assessed by the longest sequence length of patterns recalled in the Spatial Span (SSP) task of the CANTAB [67].

Magnetic resonance imaging acquisition and analysis

Participants underwent structural MRI scanning using a 3-Tesla GE scanner at Southern Radiology MRI Diagnostic Services within the Brain and Mind Research Institute, Camperdown, NSW Australia. The images where acquired using a customized MP-RAGE 3D T1-weighted sequence to resolve anatomy at high resolution (0.9mm isotropic resolution); TR = 7264msec; TE = 2784msec; pulse angle = 15; coronal orientation; FOV 230 mm³; matrix of 256 x 256 x 196.

Volumetric segmentation was performed with the FreeSurfer application version 5.1 (http://surfer.nmr.mgh.harvard.edu/) and technical details of these procedures have been previously described [68-78]. Briefly, this process involves the motion correction and averaging of two volumetric T1-weighted images [79], removal of non-brain tissue [78], transformation of the scans to the standard Talairach space, segmentation of the subcortical white matter and deep gray matter volumetric structures [71,72], intensity normalization [80], tessellation of the gray matter/white matter boundary, topology correction [70,81], surface deformation along intensity gradients to optimally place the gray/white and gray/cerebrospinal fluid borders [68,69,82], and finally cortical representations were parcellated into anatomical structures. Results were visually inspected and any inaccuracies were manually edited. FreeSurfer’s procedure for measuring cortical thickness have been validated against histological analysis [83] and manual measurements [84,85], and morphometric procedures have been demonstrated to show good test-retest reliability across scanner and field strengths [76].

Several structures clearly delineate the anterior insular cortex, as described in the Destrieux atlas and utilised in the FreeSurfer segmentation process [86]. The circular sulcus of the insula demarcates the insula along three boarders; the anterior segment separates the insula from the orbital gyri, the superior segment separates the insula from the opercular segment of the inferior frontal gyri, and the inferior segment separates the insula from the superior aspect of the superior temporal gyrus. Finally the central sulcus of the insula isolates the posterior insula (long insular gyrus) from the anterior insula (short insular gyri).

The intracranial volume (ICV) was measured to correct for differences in head size [87]. Region of interest (ROI) volumes were then corrected for ICV variation so as to provide a common space for cross-sectional morphometric comparisons.

Statistical analysis and data transformations

Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS 19.0 for Mac). ROI outliers beyond a standard deviation of ±3.0 were removed from analysis. With the exception of the Wechsler Test of Adult Reading (“predicted IQ”), all neuropsychological scores were then converted to a standardised score (i.e. z-score) and outliers beyond a standard deviation of ±2.5 were curtailed to values of +2.5 or −2.5 (depending on the direction), enabling a consistent range across variables as previously described [54,88].

Between groups (healthy, patient) analyses were conducted using independent-sample t-tests, or chi-square tests for categorical data. Pearson partial correlations (r) explored the linear correlation between the left or right anterior insula GMV (corrected for ICV) with patient demographics, class of medication dosage (mg/day), clinical scores and neurocognitive performance controlling for age (n = 133). Due to the small number of patients using stimulant medication (n = 3), correlations between stimulants and GMV was omitted. Spearman’s correlation (ρ) was used when data violated the assumptions of normality and/or contained influential data points. Follow-up analysis repeated this process controlling for years of education.

Curve estimation regression explored the quadratic correlation between the left or right anterior insula GMV (ICV corrected) with the same patient variables described above (n = 133). Curve estimation fits a quadratic curve to the existing data points to examine if there is a “U-curve” pattern to the trend, inferring that the same outcome occurs when there is any departure from normality. This study employed quadratic correlation to see if any changes in anterior insula GMV (i.e. either increases or decreases from the norm) resulted in worse clinical symptom severity and/or neurocognitive performance. Correlations were considered significant where either r ≥ .30 or ρ ≥ .30 (medium effect, explains 9% of the total variance) and p < .05 (2-tailed).

Results

Demographics

As shown in Table 1, comparison between patients and healthy participants revealed no significant difference in the distribution of gender nor predicted IQ, however patients were significantly younger [t(95.2) = 2.95, p = .004] and less educated [t(161) = 33.08, p < .001)] compared to control subjects.

Table 1.

Demographics and clinical symptom scores (± standard deviation)

Demographic variable/clinical symptom score	Healthy (n = 39)	Patients (n = 133)	Significance test
Female, percentage (f/m)	66.7% (26/13)	62.4% (83/50)	χ2(1, n = 172) = 0.24
Age, years#	23.8 ± 2.4	22.3 ± 3.7	t(95.2) = 2.95**
Predicted IQ	105.3 ± 8.2	104.1 ± 8.2	t(145) = 0.73
Education, years	15.1 ± 1.9	12.6 ± 2.4	t(161) = 33.08**
SOFAS		61.6 ± 12.5
K-10 Total		27.6 ± 8.0
HDRS Total		14.1 ± 7.4
BPRS Total		42.3 ± 10.2

Significant differences in gender were evaluated using a Pearson Chi-square test. Independent samples t-tests examined differences in age, predicted IQ and years of education. ^**p < .01 (2-tailed) ^#As Levene’s test for equality of variance was significant (p < .05) for age, results that did not assume equal variance were used.

Anterior insula GMV differences between patients and healthy participants

Table 2 shows the left and right anterior insular volumes for patients and healthy participants. The left anterior insula was significantly reduced in patients compared to healthy participants [t(170) = 2.05, p = .042], but there was no significant right anterior insula GMV difference between groups [t(79.1) = 1.85, p = .069].

Table 2.

Mean anterior insula gray matter volumes by cohort

Region of interest	Healthy mean volume (mm3 ± SD)	Patient mean volume (mm3 ± SD)	Mean difference (mm3 ± SE)	Significance test
Left anterior insula	2209 ± 214.2	2124 ± 232.2	85 ± 41.6	t(170) = 2.05*
Right anterior insula	2019 ± 182.4	1953 ± 236.1	66 ± 35.7	t(79.1) = 1.85

Independent samples t-tests examined differences between patients (n = 133) and healthy participants (n = 39) in anterior insula volumes (corrected for ICV). As Levene’s test for equality of variance was significant (p < .05) for the right anterior insula volumes, results that did not assume equal variance were used. ^*p < .05 (2-tailed). SD, standard deviation; SE, standard error.

Relationship between demographics, clinical presentation and anterior insula size

Analysing patients only, there was no linear correlation found (i.e. r < .30 or ρ < .30) between anterior insula size and either demographics (predicted IQ, age of onset of illness, years of education), medication dosage (antidepressant, antipsychotic, mood stabiliser) or clinical symptom scale scores (SOFAS, K-10, HDRS, DASS, SIAS and BPRS measures) when controlling for age (Table 3). A follow-up analysis controlling for years of education did not find any significant linear correlations (see Additional file 1).

Table 3.

Linear correlations of demographics and clinical variables to patient anterior insula GMV

Demographic/clinical variable	Left anterior insula	Right anterior insula
Predicted IQ	r(117) = .03	r(117) = −.01
Age of onset of illness	r(124) = −.02	r(124) = −.04
Years of Education	r(125) = −.10	r(125) = −.05
Antidepressant dose (mg/day)	r(110) = .09	r(110) = .02
Antipsychotic dose (mg/day)	r(110) = −.04	r(110) = −.10
Mood stabiliser dose (mg/day)	r(110) = .03	r(110) = .04
Social and occupational functioning (SOFAS)	r(119) = −.12	r(119) = −.11
Psychological distress (K-10)	r(125) = .08	r(125) = .06
Depression (HDRS)	r(121) = .10	r(121) = −.04
Depression (DASS Depression subscore)	r(116) = .11	r(116) = .00
Anxiety (DASS Anxiety subscore)	r(116) = −.01	r(116) = −.03
Stress (DASS Stress subscore)	r(116) = .08	r(116) = .03
Social interaction anxiety (SIAS)	r(122) = .18*	r(122) = .23**
Symptom severity (BPRS Total)	r(116) = .12	r(116) = .03
Positive symptoms (BPRS Positive Symptoms subscore)	r(116) = .10	r(116) = .10
Negative symptoms (BPRS Negative Symptoms subscore)	r(116) = .12	r(116) = .02
Depression (BPRS Depression subscore)	r(116) = .01	r(116) = −.09
Mania (BPRS Mania subscore)	r(116) = .08	r(116) = .06

Pearson partial correlations explored the linear correlations between the left or right anterior insula GMV (corrected for ICV) with patient demographic and clinical variables (n = 133) controlling for age. ^*p < .05; ^**p < .01 (2-tailed).

Quadratic correlation analysis of demographics, medication dosage, clinical symptoms and anterior insula size found that changes in anterior insula GMV were associated with increased psychiatric symptom severity, as measured by the BPRS score (Table 4). There was a significant correlation between BPRS Total score and the right anterior insula size [r(117) = .29, p = .006]. Similarly, there was a significant correlation between BPRS positive symptoms subscore and the right anterior insula size [r(117) = .32, p = .002].

Table 4.

Quadratic correlations of demographics and clinical variables to patient anterior insula GMV

Demographic/clinical variable	Left anterior insula	Right anterior insula
Predicted IQ	r(117) = .03	r(117) = .04
Age of onset of illness	r(124) = .07	r(124) = .09
Years of Education	r(125) = .16	r(125) = .13
Antidepressant dose (mg/day)	r(64) = .13	r(64) = .06
Antipsychotic dose (mg/day)	r(60) = .20	r(60) = .26
Mood stabiliser dose (mg/day)	r(25) = .25	r(25) = .17
Social and occupational functioning (SOFAS)	r(119) = .12	r(119) = .13
Psychological distress (K-10)	r(125) = .12	r(125) = .10
Depression (HDRS)	r(121) = .17	r(121) = .19
Depression (DASS Depression subscore)	r(116) = .13	r(116) = .02
Anxiety (DASS Anxiety subscore)	r(116) = .14	r(116) = .13
Stress (DASS Stress subscore)	r(116) = .19	r(116) = .09
Social interaction anxiety (SIAS)	r(122) = .20	r(122) = .28**
Symptom severity (BPRS Total)	r(117) = .17	r(117) = .29**
Positive symptoms (BPRS Positive Symptoms subscore)	r(117) = .17	r(117) = .32**
Negative symptoms (BPRS Negative Symptoms subscore)	r(117) = .10	r(117) = .06
Depression (BPRS Depression subscore)	r(117) = .07	r(117) = .10
Mania (BPRS Mania subscore)	r(116) = .16	r(116) = .22

Curve estimation regression explored the quadratic correlations between the left or right anterior insula GMV (corrected for ICV) with patient demographic and clinical variables (n = 133). ^**p < .01 (2-tailed).

Quadratic correlation analysis also highlights a significant correlation whereby changes in anterior insula GMV were associated with worse social anxiety as measured by the SIAS score (Table 4). There was a significant association between SIAS score and the right anterior insula size [r(122) = .28, p = .006]. Other variables analysed did not exhibit significant correlations.

Relationship between executive functioning and anterior insula size

Linear correlation analysis of executive function found that there was a positive association between anterior insula GMV and ability to perform an attentional set-shifting task (Table 5). Specifically, there was a significant correlation between IED Total errors and left anterior insula size [ρ(109) = .32, p = .016]. To confirm that performance in the IED test was not influenced by either levels of education or IQ, follow-up linear correlation analysis found that IED performance was not significantly associated with either years of education [ρ(108) = .027, p = .783] or predicted IQ [ρ(107) = .175, p = .071]. There were no significant linear correlations with the remaining measures of executive function, namely the SSP, TMT-B, RVP-A and COWAT measures. A follow-up analysis controlling for years of education found similar results; the only significant correlation was found between IED Total errors and left anterior insula size [ρ(109) = .32, p = .001; see Additional file 1].

Table 5.

Linear and quadratic correlations of neurocognitive executive functioning to patient anterior insula GMV

	Linear correlation		Quadratic correlation
Neurocognitive performance	Left anterior insula	Right anterior insula	Left anterior insula	Right anterior insula
Set Shifting (IED Total error)	ρ(109) = .32**	ρ(109) = .13	r(106) = .31**	r(106) = .22
Working Memory (SSP)	ρ(107) = .08	ρ(107) = −.00	r(104) = .20	r(104) = .16
Mental Flexibility (TMT-B)	ρ(114) = −.04	ρ(114) = .04	r(111) = .02	r(111) = .10
Sustained Attention (RVP-A)	r(106) = −.08	r(106) = −.05	r(103) = .13	r(103) = .05
Verbal Fluency (COWAT)	r(112) = .10	r(112) = .09	r(109) = .10	r(109) = .14

Spearman’s ρ (non-normal score distribution) or Pearson’s r (normal score distribution) correlation analysis explored the linear relationship between the left or right anterior insula GMV (corrected for ICV) against z-scores of neuropsychological assessments of executive function (n = 133), controlling for age. Curve estimation regression explored the quadratic correlation between the same regions of interest and neuropsychological assessments of executive function. ^**p < .01 (2-tailed).

Quadratic correlation analysis of executive function found a similar positive correlation between anterior insula GMV and the IED Total errors score (Table 5). There were significant correlations between the number of IED Total errors and left anterior insula size [r(106) = .31, p = .005]. There were no significant quadratic correlations with the remaining measures of executive function.

Discussion

The present study sought to investigate anterior insula GMV changes in a heterogeneous sample of young psychiatric patients, and if such GMV changes related to severity of clinical symptoms or impairments in neurocognitive executive functioning. This study revealed that compared to age-matched healthy participants, young psychiatric patients have reduced left anterior insula GMV that positively correlated with neurocognitive performance in an attentional set-shifting task. GMV loss or gain in the right anterior insula was associated with increased general psychiatric symptom severity (BPRS Total score) and increased positive symptoms (BPRS Positive Symptoms subscore).

The major finding from this study is that young people with emerging mental disorders have reduced left anterior insula GMV that correlates with worse executive functioning (Tables 25), in particular, set-shifting. The asymmetry of a larger left insula relative to the right insula is most apparent in humans, with less hemispheric difference seen in similar-sized lower primates [89], and this feature is hypothesised to be due to the left insula’s role in human language and language-associated functions [20]. This present study’s findings that left anterior insula GMV is positively correlated with attentional set-shifting (IED) but not verbal fluency (COWAT), working memory (SSP) or sustained attention (RPV-A) suggests that the left anterior insula may be more closely involved in attentional processing rather than vocabulary memorisation. Interestingly, attention is conspicuously affected in all psychiatric disorders [90], and hence anterior insula degradation may be a core biological marker in this neurocognitive deficit. This result reinforces the “salience network” hypothesis [22,25] that the anterior insula is involved in modulating reactivity to salient internal and extrapersonal stimuli, and this attentional executive function is impaired in young psychiatric patients with a broad variety of disorders.

The modulation of altered afferent interoceptive input, self-referential and belief-based states, and poorly predictive signals has been proposed as a neuroanatomical model for depression and anxiety [91]. One model of anxiety suggests that neurons in the anterior insula estimate an “interoceptive prediction error” which signals a mismatch between anticipated and actual bodily responses to a potentially aversive stimulus [92]. Studies demonstrating increased insula activation during emotion processing in depressive and anxiety-prone individuals [91,93] strengthens the argument that degradation of the anterior insula might result in maladaptive motivating signal for individuals to withdraw (depression) or avoid (anxiety) situations. This study found there was no significant relationship between clinical measures of general anxiety (DASS) or depression (HDRS, DASS, BPRS depression subscore) and changes in anterior insula GMV (Tables 3 and 4), highlighting that anterior insula degradation in depression and anxiety may be a functional dysregulation rather than a structural alteration.

Both increases and decreases in right anterior insula GMV were associated with more positive symptoms (Table 4), namely hostility, grandiosity, suspiciousness, hallucinations, unusual thought content, bizarre behaviour, and conceptual disorganization. It has been suggested that since the insular cortex provides connections between the limbic memory regions and sensory systems, altered insula function may result in unbalanced sensory-memory integration, such as sensory hallucinations [94]. Indeed, an fMRI study [95] of psychotic patients found auditory hallucinations co-occurred with significant hyperactivity within the right anterior insula and to a lesser extent the left insula. One structural MRI paper investigating GMV changes in schizophrenia [96] found that schizophrenic patients with hallucinations had reduced bilateral insula GMVs when compared to healthy controls, and reduced left insula GMVs when compared to schizophrenic patients without hallucinations. This present study demonstrates that in younger patients, positive symptoms are related with any imbalance of the right anterior insula GMV, consistent with the hypothesis of a hemispheric imbalance of salience switching [22,25] which may underlie dysfunctional sensory awareness and interpretation [97].

Changes in right anterior insula GMV were associated with increased clinical symptom severity as measured by the BPRS Total score (Table 4). Other clinical scales employed in this study specifically targeting depression (DASS, HDRS), anxiety (DASS), psychological stress (K-10, DASS) and social functioning (SOFAS) were not correlated with anterior insula GMV changes. Considering that the BPRS Total score encompasses a depression subscore, the significant result of the BPRS Total score is probably due to the positive symptom subscore result discussed above. However, since the BPRS Total score is the summation of 24 questions it might be considered to be the largest, most robust measure of symptom severity in this study. Accordingly, the BPRS Total score may be a robust measure of symptom severity in young people arising from changes in right anterior insula GMV.

The relationship between anterior insula GMV and clinical measures of social anxiety remains inconclusive (Tables 34). The SIAS self-report assesses fears of social interaction situations and has been demonstrated to discriminate people diagnosed with social anxiety disorder from healthy controls [98] and other anxiety disorders [62]. In this study the SIAS score had a weak but significant positive linear correlation with the right anterior insula GMV (Table 3), suggesting that reductions in anterior insula GMV equate to reductions in social anxiety and vice-versa. Future research could further investigate associations between anterior insula GMV changes and social anxiety severity using a larger cohort of patients in combination with other anxiety scales such as the clinician-administered Liebowitz Social Anxiety Scale [LSAS; [99]], the consumer-supported Social Phobia and Anxiety Inventory [SPAI; [100,101]], or the refined self-report SIAS [102] with the companion Social Phobia Scale [SPS; [62]].

The influence of medication on changes in GMV remains contentious. Antidepressants, antipsychotics and mood stabilisers can be neuroprotective in patients and animal models of psychiatric disorders [reviewed in [103]]. A recent meta-analysis [104] suggest that antipsychotic medication may contribute to some structural changes noted in psychosis patients, though the authors concede that this may be confounded by disease progression [105]. A ROI MRI study of psychosis patients [106] found that insula gray matter volume was not influenced by antipsychotic medication, and a follow-up study with bipolar patients [107] found that insula volume was not affected by lithium or valproate medication. In the young patients examined in this study, there was no evidence suggesting a relationship between antidepressants, antipsychotics or mood stabilisers with anterior insula GMV changes. Future research could examine how anterior insula GMV may be affected by specific medications, as well as the impact of medication switching over time.

Future studies can enhance the findings of this present cross-sectional study. A longitudinal protocol is needed to investigate the relationship between anterior insula GMV, clinical symptoms and neuropsychological performance over time. Furthermore, such relationships should be contrasted along a trajectory of clinical course and functional impairment as proposed by McGorry, Hickie et al [49,50]. The insular cortex has also been implicated in addictive behaviour [108] and the relationship between anterior insula GMV and drug and alcohol use requires further investigation. Finally, whilst this present study found that a group of affective/psychosis patient exhibited reduced anterior insula GMV (Table 2), increases in anterior insula GMV correlating with increased symptom severity (Table 4) may apply to patients with autism spectrum disorder which have been shown to have enlarged insula GMVs relative to healthy controls [109].

Conclusions

In summary, this study found that young people with emerging anxiety, affective or psychotic disorders have reduced left anterior insula GMV that is associated with poorer neurocognitive performance on an executive functioning task of set-shifting. Furthermore, patients with changes in right anterior insula GMV exhibited increased clinical symptom severity and more positive symptoms. By using the novel approach of examining a heterogeneous cohort of young depression, anxiety, bipolar and psychosis patients together, this study has demonstrated that insula GMV changes are associated with neurocognitive deficits and clinical symptoms in young patients. Future studies need to examine the longitudinal outcomes, clinical course and functional impairment of these findings, as well as their applicability to neurodevelopmental disorders.

Abbreviations

ARMS = At-risk mental state; BPRS = Brief Psychiatric Rating Scale; COWAT = Controlled Oral Word Association Test; DASS = Depression Anxiety and Stress Scales; FMRI = Functional magnetic resonance imaging; GMV = Gray matter volume; HDRS = Hamilton Depression Rating Scale; ICV = Intracranial volume; IED = Intra-Dimensional/ Extra-Dimensional; K-10 = Kessler-10; LSAS = Liebowitz Social Anxiety Scale; MRI = Magnetic resonance imaging; ROI = Region of interest; RVP-A = Rapid Visual Information Processing A prime measure; SD = Standard deviation; SE = Standard error; SIAS = Social Interaction Anxiety Scale; SOFAS = Social and Occupational Functioning Assessment Scale; SPAI = Social Phobia and Anxiety Inventory; SPS = Social Phobia Scale; SSP = Spatial Span; TMT-B = Trail-Making Test part B; VBM = Voxel-based morphometry.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

SNH produced the imaging analysis, statistical correlations and initial draft manuscript. IBH and MRB conceived of the study design and coordinated technical assistance. JL provided study design and interpretation of imaging analysis. DFH and SLN provided statistical analysis and interpretation of the clinical measures and neuropsychological tests. All authors contributed significantly to the interpretation of the data as well as having read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-244X/12/45/prepub

Supplementary Material

Additional file 1:

Linear correlations of anterior insula GMV with clinical/neurocognitive variables controlling for years of education. Description of data: Linear correlations of clinical variables and neurocognitive executive functioning to patient anterior insula GMV, controlling for years of education. Pearson’s r (normal score distribution) or Spearman’s ρ (non-normal score distribution) correlation analysis explored the linear relationship between the left or right anterior insula GMV (corrected for ICV) against patient demographic, clinical variables or z-scores of neuropsychological assessments of executive function (n = 133), controlling for years of education. ^*p < .05; ^**p < .01 (2-tailed).

Acknowledgments

The authors thank Manreena Kaur, Juliette Tobias-Webb, Tamara De Regt, Rico Sze Chun Lee and Django White for their assistance with data collection. We also thank individuals that participated in this study. This study was supported by the following National Health & Medical Research Council funding sources: Program Grant (No. 566529), Centres of Clinical Research Excellence Grant (No. 264611), Australia Fellowship (No. 511921) and Clinical Research Fellowship (No. 402864).